Blood investigations including full blood count, renal, liver and thyroid function tests, electrolytes, ammonia, and vitamin B12 were normal. Syphilis and Human Immunodeficiency Virus serology were negative. Serum anti-thyroid peroxidase and thyroglobulin antibodies, connective tissue disease screen (antinuclear, anti-double stranded DNA and anti-cardiolipin antibodies, and lupus anticoagulant), paraneoplastic screen (anti-CV2, Yo, Ri, Hu, amphiphysin, and Ma antibodies), and tumor markers were negative. There were no acanthocytes in the peripheral blood film. Computed tomography of the thorax, abdomen and pelvis was unremarkable.
Brain magnetic resonance imaging (MRI) showed restricted diffusion in the caudate nucleus and putamen bilaterally with cortical ribboning in the occipito-parietal region bilaterally (Figure 1) , without contrast enhancement. There was no significant brain atrophy or signal abnormalities on T1 or fluid-attenuated inversion recovery sequences. Initial electroencephalogram (EEG) showed diffuse polymorphic theta slowing with intermittent bilateral independent frontal sharp waves. Cerebrospinal fluid (CSF) analysis revealed normal opening pressure, cell counts and biochemistry. CSF autoimmune encephalitis screen (for anti-NMDAR, AMPAR-1, AMPAR-2, GABA-B, CASPR-2, and LGI-1 antibodies) was negative.
She was given a trial of intravenous methylprednisolone 1 g daily over five days, with no improvement. A repeat EEG showed a slower background rhythm with generalized periodic sharpwave complexes (PSWCs) (Figure 1) . A diagnosis of clinically probable sCJD was made based on the clinical history and progression, neuroimaging findings, evolving EEG changes and a subsequent positive CSF 14-3-3 protein result. 3 During her twelve-week hospital stay, she remained bedridden with no meaningful response. Her choreodystonic movements gradually diminished, while myoclonic jerks became increasingly frequent (video segment 2, Supplementary Video 1 in the onlineonly Data Supplement). She was eventually discharged home with community hospice support. Six months after symptom onset, she remained in a state of akinetic-mutism.
Although a definitive diagnosis of sCJD can only be made by histopathological examination, our patient more than fulfilled the minimum clinical criteria for probable sCJD based on clinical features, EEG showing PSWCs, CSF 14-3-3 positivity, and classical brain MRI abnormalities. In contrast, vCJD typically affects younger patients, shows the "pulvinar sign" on brain MRI and to our knowledge has Kingdom and has since tailed off). We believe that the other main differential diagnoses including infective encephalitis, autoimmune limbic encephalitis, toxic/metabolic syndromes, and non-convulsive status epilepticus were adequately excluded on the basis of the clinical features and extensive investigations. In this case of sCJD, we present an illustrative video showing an interesting evolution of movement disorders from predominant chorea-dystonia in the initial phase to akinetic mutism with myoclonus.
There are several single case reports of chorea in sCJD. 2 In a series of prospectively collected autopsy-proven cases, chorea was reported to be present in one out of 15 patients with sCJD. 4 Retrospective reviews of neuropathologically confirmed CJD cases revealed a 10-11% prevalence of chorea; 1, 5 however, these series did not appear to distinguish between sCJD and vCJD. In other series, the authors categorized the movement disorders as "hyperkinesias" or "abnormal movements other than myoclonus, " but the prevalence of chorea was not specifically reported; 3, 6 Brown et al. 6 (n = 230, neuropathologically verified CJD cases) specifically mentioned choreo-athetosis as a feature at illness onset in only one patient.
The movement disorders seen in CJD are thought to be a consequence of lesions in various structures including the striato-pallidal complex, the mesencephalon and the thalamus. 5 Chorea has been postulated to be due to dysfunction of the thalamus, 2 a structure commonly involved in vCJD. The clinicopathological features of CJD, particularly sCJD, are influenced by several factors including polymorphism of the prion protein gene (PRNP) involving methionine (Met) and valine (Val) at codon 129 and prion strain type (type 1 PrPSc or type 2 PrPSc). 7 Myoclonus, PSWCs on EEG, and akinesia have been associated with Met-homozygosity, while ataxia has been associated with Val-homozygosity. 1, 7 One case of sCJD with chorea was reported to be Val-homozygous. 4 In neuropathology studies, the first appearance of myoclonus in sCJD corresponds to spongiform changes in the cerebral neocortex with hypertrophic astrocytosis and ballooned neurons, while the akinetic mutism state represents an end-stage with extensive tissue rarefaction and neuron loss in the cerebral neocortex. 7 However, clinicopathological correlations for chorea in CJD have been inadequately described, and comprehensive analyses of PRNP, prion strain and neuropathology are needed to better understand these "atypical" sCJD cases.
In conclusion, although myoclonus and cerebellar ataxia are the classic movement disorders encountered in sCJD, we highlight here that chorea is a feature also compatible with the diagnosis. Awareness of this finding may potentially aid in the diagnostic workup of suspected sCJD cases. During the patient's 12-week hospital stay, the choreo-dystonic movements gradually diminished, while myoclonic jerks became increasingly frequent.
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